Inflammation as a central mechanism in Alzheimer's disease
Tóm tắt
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD. The sustained activation of the brain's resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder. In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia‐related signaling mechanisms that have been implicated in AD. Additional information on microglia signaling and a number of cytokines in AD are also reviewed. We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms.
Từ khóa
Tài liệu tham khảo
Prince M., 2016, World Alzheimer Report 2016: Improving Healthcare for People Living With Dementia: Coverage, Quality and Costs Now and in the Future
Alzheimer's Impact Movement, 2017, Alzheimer's Disease Caregivers Factsheet
Butterfield D.A., 2012, Amyloid β‐Peptide (1–42)‐Induced oxidative stress in Alzheimer disease: Importance in disease pathogenesis and progression, Antioxid Redox Signal, 19, 823, 10.1089/ars.2012.5027
Šimić G., 2016, Tau Protein Hyperphosphorylation and aggregation in Alzheimer's disease and other tauopathies, and possible neuroprotective strategies, Biomolecules, 6, 10.3390/biom6010006
Morris G.P., 2014, Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease, Acta Neuropathol Commun, 2
Gomez‐Nicola D., 2015, Post‐mortem analysis of neuroinflammatory changes in human Alzheimer's disease, Alzheimers Res Ther, 7, 10.1186/s13195-015-0126-1
Meraz‐Ríos M.A., 2013, Inflammatory process in Alzheimer's Disease, Front Integr Neurosci, 7
Rubio‐Perez J.M., 2012, A Review: Inflammatory process in Alzheimer's disease, role of cytokines, ScientificWorldJournal, 2012
Herrero M.‐T., 2015, Inflammation in Parkinson's disease: role of glucocorticoids, Front Neuroanat, 9
Ellrichmann G., 2013, The role of the immune system in Huntington's disease, Clin Dev Immunol, 2013, 10.1155/2013/541259
Silajdžić E., 2013, A critical evaluation of inflammatory markers in Huntington's Disease plasma, J Huntington's Dis, 2, 125, 10.3233/JHD-130049
Breunig J., 2013, Brain injury, neuroinflammation and Alzheimer's disease, Front Aging Neurosci, 5, 10.3389/fnagi.2013.00026
Cappellano G., 2013, Immunity and inflammation in neurodegenerative diseases, Am J Neurodegenerative Dis, 2, 89
Sarma J.D., 2014, Microglia‐mediated neuroinflammation is an amplifier of virus‐induced neuropathology, J NeuroVirology, 20, 122, 10.1007/s13365-013-0188-4
Glenn J.A., 1992, Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability, J Anat, 180, 109
Mrak R.E., 2012, Microglia in Alzheimer Brain: A neuropathological perspective, Int J Alzheimer's Dis
Bhaskar K., 2014, Microglial derived tumor necrosis factor‐α drives Alzheimer's disease‐related neuronal cell cycle events, Neurobiol Dis, 62, 10.1016/j.nbd.2013.10.007
Bemiller S.M., 2017, TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy, Mol Neurodegener, 12, 10.1186/s13024-017-0216-6
Jin S.C., 2015, TREM2 is associated with increased risk for Alzheimer's disease in African Americans, Mol Neurodegener, 10
Ulrich J.D., 2014, Altered microglial response to A beta plaques in APPPS1‐21 mice heterozygous for TREM2, Mol Neurodegener, 9, 10.1186/1750-1326-9-20
Fuhrmann M., 2010, Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease, Nat Publishing Group, 13, 411
Li Y., 2016, Implications of GABAergic Neurotransmission in Alzheimer's disease, Front Aging Neurosci, 8
Le Meur K., 2012, GABA release by hippocampal astrocytes, Front Comput Neurosci, 6, 10.3389/fncom.2012.00059
Chang R., 2017, Tumor necrosis factor α Inhibition for Alzheimer's Disease, J Cent Nervous Syst Dis, 9
Cacabelos R., 1994, Brain interleukin‐1 beta in Alzheimer's disease and vascular dementia, Methods Findings Exp Clin Pharmacol, 16, 141
Farrar W.L., 1987, Visualization and characterization of interleukin 1 receptors in brain, J Immunol, 139, 459, 10.4049/jimmunol.139.2.459
Chao C.C., 1994, Transforming growth factor beta in Alzheimer's disease, Clin Diagn Lab Immunol, 1, 109, 10.1128/cdli.1.1.109-110.1994
Thakur M.K., 2012, Traumatic brain injury: A risk factor of Alzheimer's disease, Neurosci Biobehav Rev, 36, 1376, 10.1016/j.neubiorev.2012.02.013
Djordievic J., 2016, Traumatic brain injury as a risk factor for Alzheimer's disease: is inflammatory signaling a key player?, Curr Alzheimer Res, 13, 730, 10.2174/1567205013666160222110320
Bonadonna R.C., 1991, Glucose metabolism in obesity and type 2 diabetes, Diabete & Metabolisme, 17, 112
Monte de S.M., 2001, Ethanol impairs insulin‐stimulated mitochondrial function in cerebellar granule neurons, Cell Mol Life Sci, 58, 1950, 10.1007/PL00000829
Li W., 2017, Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker Aβ1‐42 in Alzheimer's Disease Neuroimaging Initiative participants, Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 10, 94, 10.1016/j.dadm.2017.11.002
Freeman L.R., 2011, Vascular changes in rat hippocampus following a high saturated fat and cholesterol diet, J Cereb Blood Flow Metab, 32, 643, 10.1038/jcbfm.2011.168
Perry V.H., 2014, Microglial priming in neurodegenerative disease, Nat Publishing Group, 10, 217
Ledo J.H., 2016, Cross talk between brain innate immunity and serotonin signaling underlies depressive‐like behavior induced by Alzheimer's amyloid‐ oligomers in mice, J Neurosci, 36, 12106, 10.1523/JNEUROSCI.1269-16.2016